Published in Ann Oncol on June 23, 2011
Emerging targeted agents in metastatic breast cancer. Nat Rev Clin Oncol (2013) 1.59
Targeting Src family kinases in anti-cancer therapies: turning promise into triumph. Trends Pharmacol Sci (2011) 1.45
Safety of bosutinib versus imatinib in the phase 3 BELA trial in newly diagnosed chronic phase chronic myeloid leukemia. Am J Hematol (2014) 1.22
Identification of a Src tyrosine kinase/SIAH2 E3 ubiquitin ligase pathway that regulates C/EBPδ expression and contributes to transformation of breast tumor cells. Mol Cell Biol (2011) 0.97
Endothelial FAK as a therapeutic target in disease. Microvasc Res (2011) 0.96
A conserved water-mediated hydrogen bond network defines bosutinib's kinase selectivity. Nat Chem Biol (2013) 0.95
Activation of rapid oestrogen signalling in aggressive human breast cancers. EMBO Mol Med (2012) 0.91
S6K1 promotes invasiveness of breast cancer cells in a model of metastasis of triple-negative breast cancer. Am J Transl Res (2014) 0.90
Activation of abl family kinases in solid tumors. Genes Cancer (2012) 0.89
Clinical review: kinase inhibitors: adverse effects related to the endocrine system. J Clin Endocrinol Metab (2013) 0.85
Bosutinib plus capecitabine for selected advanced solid tumours: results of a phase 1 dose-escalation study. Br J Cancer (2014) 0.79
Bone antiresorptive agents in the treatment of bone metastases associated with solid tumours or multiple myeloma. Bonekey Rep (2015) 0.79
Phase II study of saracatinib (AZD0530) in patients with previously treated metastatic colorectal cancer. Invest New Drugs (2015) 0.76
Bone-Targeted Agents for the Management of Breast Cancer Patients with Bone Metastases. J Clin Med (2013) 0.76
Drug monographs: bosutinib and regorafenib. Hosp Pharm (2013) 0.76
Prevention of Bone Metastases in Breast Cancer Patients. Therapeutic Perspectives. J Clin Med (2014) 0.75
Novel approaches in the pharmacotherapy of skeletal-related events in metastatic castrate-resistant prostate cancer. Anticancer Res (2012) 0.75
Bone-targeted therapy in metastatic breast cancer - all well-established knowledge? Breast Care (Basel) (2014) 0.75
Role of estrogen receptors and Src signaling in mechanisms of bone metastasis by estrogen receptor positive breast cancers. J Transl Med (2017) 0.75
Linkage disequilibrium in the human genome. Nature (2001) 17.24
Kirsten ras mutations in patients with colorectal cancer: the 'RASCAL II' study. Br J Cancer (2001) 5.36
Efficacy according to biomarker status of cetuximab plus FOLFOX-4 as first-line treatment for metastatic colorectal cancer: the OPUS study. Ann Oncol (2011) 4.95
A genomewide screen in multiplex rheumatoid arthritis families suggests genetic overlap with other autoimmune diseases. Am J Hum Genet (2001) 4.17
THE ISOLATION OF POLIOMYELITIS VIRUS FROM HUMAN EXTRA-NEURAL SOURCES. III. PERSISTENCE OF VIRUS IN STOOLS AFTER ACUTE INFECTION. J Clin Invest (1946) 3.88
Eosinophilic bronchitis is an important cause of chronic cough. Am J Respir Crit Care Med (1999) 3.84
Sputum eosinophilia and short-term response to prednisolone in chronic obstructive pulmonary disease: a randomised controlled trial. Lancet (2000) 3.63
INSECTS AND EPIDEMIOLOGY OF POLIOMYELITIS. Science (1942) 3.59
FLIES AS CARRIERS OF POLIOMYELITIS VIRUS IN URBAN EPIDEMICS. Science (1941) 3.48
Epithelial cell polarity and cell junctions in Drosophila. Annu Rev Genet (2001) 3.22
Complete mitochondrial genome sequences of two extinct moas clarify ratite evolution. Nature (2001) 3.12
POLIOMYELITIS VIRUS IN FLY-CONTAMINATED FOOD COLLECTED AT AN EPIDEMIC. Science (1945) 3.04
Protective mucosal immunity elicited by targeted iliac lymph node immunization with a subunit SIV envelope and core vaccine in macaques. Nat Med (1996) 2.96
The genetics revolution and the assault on rheumatoid arthritis. Arthritis Rheum (1999) 2.92
THE NATURAL HISTORY OF HUMAN POLIOMYELITIS : I. DISTRIBUTION OF VIRUS IN NERVOUS AND NON-NERVOUS TISSUES. J Exp Med (1941) 2.68
Occupational asthma due to porcine pancreatic amylase. Occup Environ Med (1997) 2.62
NATURE OF NON-PARALYTIC AND TRANSITORY PARALYTIC POLIOMYELITIS IN RHESUS MONKEYS INOCULATED WITH HUMAN VIRUS. J Exp Med (1941) 2.54
Population pharmacokinetics/pharmacodynamics of docetaxel in phase II studies in patients with cancer. J Clin Oncol (1998) 2.52
The effectiveness of exercise for the prevention and treatment of antenatal depression: systematic review with meta-analysis. BJOG (2014) 2.45
Patient preference and pharmacokinetics of oral modulated UFT versus intravenous fluorouracil and leucovorin: a randomised crossover trial in advanced colorectal cancer. Eur J Cancer (2002) 2.34
Development and mapping of microsatellite (SSR) markers in wheat. Theor Appl Genet (2005) 2.27
mtDNA and the origin of the Icelanders: deciphering signals of recent population history. Am J Hum Genet (2000) 2.23
Rotavirus and central nervous system symptoms: cause or contaminant? Case reports and review. Clin Infect Dis (2001) 2.23
Estimating Scandinavian and Gaelic ancestry in the male settlers of Iceland. Am J Hum Genet (2000) 2.22
Submillimetre galaxies reside in dark matter haloes with masses greater than 3 × 10(11) solar masses. Nature (2011) 2.21
Multicenter, randomized comparative study of two doses of paclitaxel in patients with metastatic breast cancer. J Clin Oncol (1996) 2.17
Irreversible corneal decompensation in patients treated with topical dorzolamide. Am J Ophthalmol (1999) 2.17
Direct measurement of attentional dwell time in human vision. Nature (1994) 2.15
Ipilimumab in combination with paclitaxel and carboplatin as first-line therapy in extensive-disease-small-cell lung cancer: results from a randomized, double-blind, multicenter phase 2 trial. Ann Oncol (2012) 2.14
The association of endogenous hormone concentrations and bone mineral density measures in pre- and perimenopausal women of four ethnic groups: SWAN. Osteoporos Int (2003) 2.13
Topical mitomycin-C for subepithelial fibrosis after refractive corneal surgery. Ophthalmology (2000) 2.11
Metastatic malignant mesothelioma presenting as colonic polyps. Hum Pathol (1997) 2.09
Efficacy and safety of high-dose rhesus-human reassortant rotavirus vaccine in Native American populations. J Pediatr (1997) 2.07
Restricted attentional capacity within but not between sensory modalities. Nature (1997) 1.96
Linkage and association analysis of angiotensin I-converting enzyme (ACE)-gene polymorphisms with ACE concentration and blood pressure. Am J Hum Genet (2001) 1.91
Survey of resistance of herpes simplex virus to acyclovir in northwest England. Antimicrob Agents Chemother (1998) 1.89
Characterization of gelatinase from pig polymorphonuclear leucocytes. A metalloproteinase resembling tumour type IV collagenase. Biochem J (1989) 1.89
The diagnostic accuracy of the rectal biopsy in acute graft-versus-host disease: a prospective study of thirteen patients. Gastroenterology (1980) 1.88
Competitive brain activity in visual attention. Curr Opin Neurobiol (1997) 1.84
Airway inflammation, airway responsiveness and cough before and after inhaled budesonide in patients with eosinophilic bronchitis. Eur Respir J (2000) 1.81
mtDna and the islands of the North Atlantic: estimating the proportions of Norse and Gaelic ancestry. Am J Hum Genet (2001) 1.81
Acanthamoeba keratitis. A growing problem in soft and hard contact lens wearers. Ophthalmology (1987) 1.73
The Ontario Prehospital Advanced Life Support (OPALS) Study: rationale and methodology for cardiac arrest patients. Ann Emerg Med (1998) 1.73
Modifiable factors associated with improved cardiac arrest survival in a multicenter basic life support/defibrillation system: OPALS Study Phase I results. Ontario Prehospital Advanced Life Support. Ann Emerg Med (1999) 1.71
Inverse relation between prostate-specific antigen and insulin-like growth factor-binding protein 3 in bone metastases and serum of patients with prostate cancer. Lancet (1999) 1.70
The differentiation of semantic dementia and frontal lobe dementia (temporal and frontal variants of frontotemporal dementia) from early Alzheimer's disease: a comparative neuropsychological study. Neuropsychology (1999) 1.68
Factors associated with early failure of arteriovenous fistulae for haemodialysis access. Eur J Vasc Endovasc Surg (1996) 1.65
Bevacizumab-based therapy for advanced small bowel adenocarcinoma. Gut (2008) 1.64
Cervical epidural steroid injection with intrinsic spinal cord damage. Two case reports. Spine (Phila Pa 1976) (1998) 1.61
Initiation of reovirus mRNA synthesis in vitro. Nat New Biol (1971) 1.61
Genetic evidence for a family-based Scandinavian settlement of Shetland and Orkney during the Viking periods. Heredity (Edinb) (2005) 1.59
Surgical correction of hypotropias associated with thyroid dysfunction. Arch Ophthalmol (1965) 1.51
A small molecule designed to bind to the adenine nucleotide pocket of Hsp90 causes Her2 degradation and the growth arrest and differentiation of breast cancer cells. Chem Biol (2001) 1.49
Photic maculopathy after pterygium excision. Am J Ophthalmol (1999) 1.49
Docetaxel is a major cytotoxic drug for the treatment of advanced breast cancer: a phase II trial of the Clinical Screening Cooperative Group of the European Organization for Research and Treatment of Cancer. J Clin Oncol (1995) 1.49
POLIOMYELITIS IN A LABORATORY WORKER EXPOSED TO THE VIRUS. Science (1941) 1.48
The role of plasminogen activators in the regulation of connective tissue metalloproteinases. Ann N Y Acad Sci (1992) 1.48
Experimental infection studies of UK Culicoides species midges with bluetongue virus serotypes 8 and 9. Vet Rec (2008) 1.47
AP-1-mediated invasion requires increased expression of the hyaluronan receptor CD44. Mol Cell Biol (1997) 1.46
Treatment of unruptured intracranial aneurysms: a nationwide assessment of effectiveness. AJNR Am J Neuroradiol (2007) 1.44
Multisite phosphotyping of the ErbB-2 oncoprotein in human breast cancer. Mol Diagn (2001) 1.44
Reprinted article "Factors associated with early failure of arteriovenous fistulae for haemodialysis access". Eur J Vasc Endovasc Surg (2011) 1.44
Closed-chamber capsulorhexis for cataract extraction combined with penetrating keratoplasty. J Cataract Refract Surg (1998) 1.44
THE ISOLATION OF POLIOMYELITIS VIRUS FROM HUMAN EXTRA-NEURAL SOURCES. II. COMPARISON OF VIRUS CONTENT OF BLOOD, OROPHARYNGEAL WASHINGS, AND STOOLS OF CONTACTS. J Clin Invest (1946) 1.43
Hepatitis B antigen in saliva and mouth washings. Lancet (1972) 1.42
Incidence and predictors of central venous catheter related infection in intensive care patients. Anaesth Intensive Care (1999) 1.40
The influence of carbogen breathing on tumour tissue oxygenation in man evaluated by computerised p02 histography. Br J Cancer (1992) 1.39
Regulation of matrix metalloproteinase activity. Ann N Y Acad Sci (1994) 1.39
Pre-operative systemic (neo-adjuvant) therapy with trastuzumab and docetaxel for HER2-overexpressing stage II or III breast cancer: results of a multicenter phase II trial. Ann Oncol (2005) 1.33
THE NATURAL HISTORY OF HUMAN POLIOMYELITIS : II. ELIMINATION OF THE VIRUS. J Exp Med (1941) 1.32
Immunoscintigraphy of colon carcinoma. J Nucl Med (1984) 1.31
Antibiotic treatment of venereal disease and Reiter's syndrome in a Greenland population. Arthritis Rheum (1992) 1.31
Breast-feeding and the risk of life-threatening rotavirus diarrhea: prevention or postponement? Pediatrics (1993) 1.28
Polymorphisms of renin-angiotensin genes among Nigerians, Jamaicans, and African Americans. Hypertension (1996) 1.27
Angiotensinogen gene in human hypertension. Lack of an association of the 235T allele among African Americans. Hypertension (1994) 1.26
A common-source outbreak of callitrichid hepatitis in captive tamarins and marmosets. J Infect Dis (1993) 1.26
Cytosine at the 3'-termini of reovirus genome and in vitro mRNA. Nat New Biol (1971) 1.25
EORTC Early Clinical Studies Group early phase II trial of S-1 in patients with advanced or metastatic colorectal cancer. Br J Cancer (2003) 1.25
Intraperitoneal recombinant interferon gamma in ovarian cancer patients with residual disease at second-look laparotomy. J Clin Oncol (1996) 1.25
Phase II trial with S-1 in chemotherapy-naïve patients with gastric cancer. A trial performed by the EORTC Early Clinical Studies Group (ECSG). Eur J Cancer (2003) 1.24
Gene order of RNA bacteriophage M 12. Nature (1970) 1.24
Induced sputum eicosanoid concentrations in asthma. Am J Respir Crit Care Med (1999) 1.24
Review article: safe amounts of gluten for patients with wheat allergy or coeliac disease. Aliment Pharmacol Ther (2006) 1.24
Physiological mechanisms for metalloproteinase activation. Matrix Suppl (1992) 1.24
Medical Information Management System (MIMS) CareWindows. Proc Annu Symp Comput Appl Med Care (1991) 1.23
Efficacy and tolerability of bevacizumab plus capecitabine as first-line therapy in patients with advanced hepatocellular carcinoma. Br J Cancer (2010) 1.22
Microfabricated surface-electrode ion trap for scalable quantum information processing. Phys Rev Lett (2006) 1.21
Prenatal alcohol exposure alters the patterns of facial asymmetry. Alcohol (2010) 1.21
Maximum-likelihood generalized heritability estimate for blood pressure in Nigerian families. Hypertension (1999) 1.21
Cervical presentations of thymic anomalies in children. Int J Pediatr Otorhinolaryngol (2004) 1.20
Endogenous hormones and bone turnover markers in pre- and perimenopausal women: SWAN. Osteoporos Int (2003) 1.19
The puzzle of hypertension in African-Americans. Sci Am (1999) 1.18
PAX3 gene structure and mutations: close analogies between Waardenburg syndrome and the Splotch mouse. Hum Mol Genet (1994) 1.16
RASSF2 associates with and stabilizes the proapoptotic kinase MST2. Oncogene (2009) 1.16
Induced sputum inflammatory mediator concentrations in eosinophilic bronchitis and asthma. Am J Respir Crit Care Med (2000) 1.15
ACE, angiotensinogen and obesity: a potential pathway leading to hypertension. J Hum Hypertens (1997) 1.14
Commitment to change statements: a way of understanding how participants use information and skills taught in an educational session. J Contin Educ Health Prof (2001) 1.14
T-bet expression in intratumoral lymphoid structures after neoadjuvant trastuzumab plus docetaxel for HER2-overexpressing breast carcinoma predicts survival. Br J Cancer (2011) 1.14